Keyphrases
Meta-analysis
100%
Prognostic Factors
100%
Systematic Meta-analysis
100%
Spinal Metastasis
100%
Radiotherapy
66%
Hazard Ratio
50%
Tumor
50%
Karnofsky Performance Status
50%
Poor Prognostic Factors
50%
Independent Prognostic Factor
50%
Confidential Interval
50%
PubMed
33%
Before Surgery
33%
Motor Deficits
33%
Embase
33%
Ambulatory Status
33%
Metastatic Spine Disease
33%
Non-ambulatory
33%
Tomita Score
33%
Vertebral Metastases
33%
Inclusion Criteria
16%
Male Gender
16%
Multivariate Analysis
16%
Survival Prediction
16%
Rapid Growth
16%
Search Terms
16%
Bone Metastasis
16%
Patient Survival
16%
Neurologic Deficit
16%
Systematic Literature Review
16%
Publication Bias
16%
Cancer Diagnosis
16%
Patient Samples
16%
Database Search
16%
Cancer-specific
16%
Eastern Cooperative Oncology Group
16%
Retrospective Cohort
16%
Symptomatic Spinal Metastases
16%
Visceral Metastases
16%
Newcastle-Ottawa Scale
16%
Funnel Plot
16%
Prognostic Scoring System
16%
Egger's Test
16%
Multiple Bone Metastases
16%
Qualitative Synthesis
16%
Moderate Growth
16%
Literature Review Analysis
16%
Prognostic Survival
16%
Publication Analysis
16%
Spinal Metastatic Disease
16%
Site Development
16%
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
100%
Prognostic Factor
100%
Spinal Cord Metastasis
100%
Radiation Therapy
36%
Hazard Ratio
27%
Karnofsky Performance Status
27%
Bone Metastasis
18%
Tumor Progression
18%
Spine Disease
18%
Spine Metastasis
18%
Malignant Neoplasm
9%
Neoplasm
9%
Metastatic Carcinoma
9%
Cohort Study
9%
Decision Making
9%
Cancer Diagnosis
9%
Cohort Analysis
9%
Multivariate Analysis
9%
Scoring System
9%
Oncology
9%
Observational Study
9%
Outcome Assessment
9%
Survival Prediction
9%
Visceral Metastasis
9%
Funnel Plot
9%
Diseases
9%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
100%
Cohort Study
100%
Embase
100%
Medline
100%
Observational Study
50%
Multivariate Analysis
50%
Decision Making
50%
Survival Prediction
50%
Pharmacology, Toxicology and Pharmaceutical Science
Spinal Cord Metastasis
100%
Cohort Study
33%
Tumor Growth
33%
Malignant Neoplasm
33%
Bone Metastasis
33%
Spine Disease
33%
Spine Metastasis
33%
Neoplasm
16%
Observational Study
16%
Metastasis
16%
Survival Prediction
16%
Visceral Metastasis
16%
Diseases
16%